This editorial analyzes the role of intravascular hemolysis in hemolytic disorders, suggesting new insights into inflammatory diseases.
Editorial FocusIntravascular Hemolysis as a Converging Mechanism in Hemolytic DisordersJustin A. Courson, Arun SainiJustin A. Courson*Correspondence: 1 Baylor Plz, Houston, TX 77030, [email protected]Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States of AmericaBaylor College of Medicine, Houston, TX, United States of America* and Arun SainiCenter for Translational Research on Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States of AmericaBaylor College of Medicine, Houston, TX, United States of AmericaPublished Online:13 Oct 2025https://doi.org/10.1152/ajpheart.00773.2025MoreSections PDF (108 KB) ToolsExport citationAdd to favoritesTrack citations ShareShare onFacebookXLinkedInWeChat Previous Back to Top Next Download PDF FiguresReferencesRelatedInformation More from this issue > Articles in PressPublished 13 Oct 2025 Crossmark Copyright & PermissionsCopyright © 2025 The Authors.Licensed under Creative Commons Attribution CC-BY 4.0. Published by the American Physiological Society.https://doi.org/10.1152/ajpheart.00773.2025PubMed41083249History Received 3 October 2025 Accepted 7 October 2025 Published online 13 October 2025 Metrics
No takes yet. Share an insight, caveat, or question.
Courson et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: